ADMA Biologics Inc (OTCBB - OTCQB:ADMA)

9.90
Data as of 2:44pm ET
 -0.07 / -0.70%
Today’s Change
6.52
Today|||52-Week Range
10.50
+26.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$92.6M

Company Description

ADMA Biologics, Inc. operates as a specialty immune globulin company, which engages in the development and commercialization of human plasma and plasma-derived therapeutics. The company's targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. It operates through two segments: Plasma Collection Center and Research & Development. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Contact Information

ADMA Biologics, Inc.
465 State Route 17
Ramsey New Jersey 07446-2012
P:(201) 478-5552
Investor Relations:

Employees

Shareholders

Mutual fund holders8.46%
Other institutional4.98%
Individual stakeholders12.77%

Top Executives

Adam S. GrossmanPresident, Chief Executive Officer & Director
Brian LenzChief Financial Officer & Vice President
James MondExecutive VP, Chief Scientific & Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.